Privo Technologies, Inc.

Privo Technologies is a clinical stage nanomedicine company spun out of MIT's Langer Lab. We are currently focused on treating oral cancer topically and locally

[Privo Technologies, Inc. @PrivoTechnology]

Exciting News Coming Out of Privo Today -- Read more below! #safecancertreatment #oralcancer #solidtumors #localcancertreatment https://t.co/Dl7SQmqGjR

[Privo Technologies, Inc. @PrivoTechnology]

We are very excited to present our Phase II data at The American Society of Clinical Oncology 2021. Dr. Nishant Agrawal, the Chief of Head and Neck Surgery at Chicago Medicine will be presenting the data, available here: https://t.co/nTueUfMBWt. #ASCO21

[Privo Technologies, Inc. @PrivoTechnology]

Privo Technologies would like to announce that the company has received Orphan Designation from the Food and Drug... https://t.co/Q84tcezVJO

[Privo Technologies, Inc. @PrivoTechnology]

Check out Privo's new video sponsored by the National Science Foundation (NSF). Thanks NSF for the Phase I grant... https://t.co/ykgD5QuNNF

[Privo Technologies, Inc. @PrivoTechnology]

Privo Technologies announces that the company has received approval of a recently submitted Phase II NIH grant... https://t.co/smNI6hS8Yu

[Privo Technologies, Inc. @PrivoTechnology]

Privo Technologies announces that the company has received approval of a recently submitted Phase II NIH grant... https://t.co/0l0pAjBuZD

[Privo Technologies, Inc. @PrivoTechnology]

Privo Technologies received approval today of a recently submitted FastTrack (Phase I and Phase II) NIH grant... https://t.co/31jcid5t0N

[Privo Technologies, Inc. @PrivoTechnology]

Privo Technologies received approval today of a recently submitted FastTrack (Phase I and Phase II) NIH grant... https://t.co/fqvNmkg1XZ

[Privo Technologies, Inc. @PrivoTechnology]

At the RESI conference in Boston! Privo is proud to serve as both an exhibitor and presenter at RESI, and would... https://t.co/EJDvRkiWHY

[Privo Technologies, Inc. @PrivoTechnology]

Privo Technologies has completed the company’s expansion to a new 3000 square foot facility just outside of... https://t.co/6LlHZN5XTR

[Privo Technologies, Inc. @PrivoTechnology]

Privo Technologies has completed the company’s expansion to a new 3000 square foot facility just outside of... https://t.co/QsGBMSarmi

[Privo Technologies, Inc. @PrivoTechnology]

Privo Technologies has completed the company’s expansion to a new 3000 square foot facility just outside of... https://t.co/ul6fQacI23

[Privo Technologies, Inc. @PrivoTechnology]

Privo Technologies would like to announce that the company has received Orphan Designation from the Food and Drug... https://t.co/0UDNLXy37o

[Privo Technologies, Inc. @PrivoTechnology]

Privo Technologies would like to announce that the company has received Orphan Designation from the Food and Drug... https://t.co/gRYkjvYjvN

[Privo Technologies, Inc. @PrivoTechnology]

Privo Technologies is pleased to announce that the company has just completed a face to face Type B Pre-IND... https://t.co/yr6gmyKG3P

[Privo Technologies, Inc. @PrivoTechnology]

Privo Technologies is pleased to announce that the company has won the 2016 National Tibbetts award for... https://t.co/OzUOjpHJZg

[Privo Technologies, Inc. @PrivoTechnology]

https://t.co/8e3cjjliSO https://t.co/0rD0Juasbk

[Privo Technologies, Inc. @PrivoTechnology]

National Science Foundation /Prvio Exhibiting at Bio International https://t.co/GnaSQaZ7Oa

[Privo Technologies, Inc. @PrivoTechnology]

I posted 2 photos on Facebook https://t.co/VRpXXB2TTG

[Privo Technologies, Inc. @PrivoTechnology]

At the US patent office